سعر لانزوبرازول 15 مجم 5 كبسول 2026

Lansoprazole 15 mg oral capsules, pack of 5; proton pump inhibitor. Manufacturer not identified by the Egyptian directories opened.

• Short-term treatment of active duodenal ulcer and maintenance of healed duodenal ulcer (adults).Population: AdultsDailyMed (U.S. National Library of Medicine)
• Eradication of H. pylori (triple therapy with amoxicillin and clarithromycin, or dual therapy with amoxicillin) to reduce duodenal ulcer recurrence (adults).Population: AdultsDailyMed (U.S. National Library of Medicine)
• Benign gastric ulcer; healing and risk reduction of NSAID-associated gastric ulcer (adults).Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions (1% or more): diarrhoea, abdominal pain, nausea and constipation.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to any component (reactions may include anaphylaxis, angioedema, bronchospasm, acute tubulointerstitial nephritis, urticaria).International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Concomitant use with rilpivirine-containing products.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Symptomatic response does not exclude gastric malignancy; consider further evaluation.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Acute tubulointerstitial nephritis, Clostridioides difficile-associated diarrhoea, severe cutaneous adverse reactions and cutaneous/systemic lupus erythematosus have been reported; discontinue and evaluate as appropriate.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Long-term and multiple daily-dose PPI therapy may increase the risk of osteoporosis-related fractures; prolonged use may cause hypomagnesaemia, vitamin B12 deficiency (use longer than 3 years) and fundic gland polyps (especially beyond 1 year); use the shortest appropriate duration.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Rilpivirine, atazanavir, nelfinavir and other antiretroviralsReduced exposure of rilpivirine (contraindicated), atazanavir and nelfinavir (avoid) may reduce antiviral effect; saquinavir exposure may increase.DailyMed (U.S. National Library of Medicine)
• WarfarinIncreased INR and prothrombin time reported; monitor INR and adjust warfarin.DailyMed (U.S. National Library of Medicine)
• Methotrexate (high dose)May elevate and prolong methotrexate levels; consider temporary withdrawal of lansoprazole.DailyMed (U.S. National Library of Medicine)

• Published observational studies overall do not indicate an association of adverse pregnancy outcomes with lansoprazole; in rats, doses about 6.4 times the maximum human dose during organogenesis through lactation reduced offspring femur weight/length and growth-plate thickness, associated with lower body-weight gain.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No information on presence in human milk or effects on the breastfed infant or milk production; lansoprazole and metabolites are present in rat milk. Weigh benefits of breastfeeding against maternal need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Lansoprazole: Suppresses gastric acid secretion by inhibiting the H+/K+-ATPase (proton pump) of gastric parietal cells.